In Brief: Advanced Viral Research's Reticulose
Executive Summary
Advanced Viral Research's Reticulose: FDA places anti-viral drug on clinical hold Jan. 27, the Miami R&D company discloses Feb. 3. AVR was instructed to cease all activities of a previously-announced pilot AIDS study of the drug effects on viral load of HIV-positive persons to be conducted at a South Florida hospital...